MedMap

WHO ARE WE?

MedMap helps biomedical innovators move from evidence to market and from molecular ideas to optimized drug candidates through Clinical Validation & Market Access and AI-driven Drug Optimization services.

Contact Us

We deliver focused solutions for biomedical innovators through three connected business lines:

Scalable BioMedical Platforms

Clinical Validation

Local clinical evidence generation, KOL engagement, validation planning and performance evidence for MedTech, IVD and SaMD teams.

Tailored System Integration

AI-driven Drug Optimization

Closed-loop DMTA, molecule generation, QSAR, 42-endpoint ADMET-AI, docking and PK/PD simulation for drug discovery teams.

Market-access Innovation

Market Access Platform

A digital market-access platform connecting regional evidence, regulatory pathways, distributors, hospital stakeholders and commercialization workflows across Southeast Asia.

Vision

A future where biomedical innovation reaches patients faster through stronger evidence, smarter optimization and practical market access across Southeast Asia.

Medical team vision

Mission

Our mission is to help MedTech, IVD, digital health and biopharma teams de-risk development, validate locally, optimize scientifically and commercialize with confidence.

Medical team mission